Prostate Cancer
uPA mRNA and uPAR mRNA expression seen in adenocarcinomas & benign hyperplasias
Published in Medical Devices and Surgical Technology Week, April 17th, 2005
According to recently published research in the International Journal of Cancer, "The plasminogen activation (PA) cascade participates in degradation of extracellular matrix during cancer invasion.
"We have studied the expression of urokinase-type plasminogen activator (uPA) mRNA, uPA receptor (uPAR) mRNA and immunoreactivity, and type-1 plasminogen activator inhibitor (PAI-1) mRNA and immunoreactivity in 16 prostate adenocarcinomas and 9 benign prostate hyperplasias."
"uPA mRNA and uPA,R mRNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Brucellosis
Plasmapheresis effective for infection-induced thrombotic microangiopathy - Cochlear Implants
Short electrode array has good long-term outcome in children - Hematology
Microfluidic device enables efficient separation of leukocytes from whole blood - Microarray Analysis
Novel QRT-PCR-based exponential sample amplification method developed - Surgical Technology
Novel optical coherence tomograph useful in anterior segment surgery - Acute Myocardial Infarction
Multivessel PCI has comparable outcome to single-vessel PCI in AMI patients - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
